Queensland

Dr Loke Bhatia

BSc(Hons) MBChB MRCP(UK) FRACP PhD
Interventional Cardiologist
Member of the Royal College of Physicians UK
Fellow of the Royal Australasian College of Physicians
Doctor of Philosophy (PhD)

Special clinical interest in all aspects of coronary intervention and stenting, cardiac CT and general cardiology.


About Dr Loke Bhatia

Dr Loke Bhatia is an Interventional Cardiologist with over 12 years of consultant-level experience in the United Kingdom. He has extensive expertise in the investigation and treatment of heart disease, including complex coronary angioplasty and stenting.

Originally from Singapore, Dr Bhatia moved to the United Kingdom following compulsory military service to study Medicine at the University of Bristol. During his medical training, he achieved First-Class Honours in an intercalated degree in Anatomical Science and was also awarded the Lilly Prize in Medicine. He subsequently obtained Membership of the Royal College of Physicians of London before undertaking specialist Cardiology training in the Wessex Deanery.

His interventional training included a fellowship at Glenfield Hospital under the late Professor Gershlick, one of the UK’s pioneering interventional cardiologists. Dr Bhatia went on to complete a PhD at the University of Southampton, investigating cardiovascular risk biomarkers in metabolic fatty liver disease. His research has been published extensively in peer-reviewed journals, including the European Heart Journal, and has attracted almost 2,000 citations internationally.

Prior to relocating to Australia, Dr Bhatia worked for more than a decade as a Consultant Cardiologist in the UK, primarily as a substantive Interventional Cardiologist within the National Health Service in Devon. He was also Director of the Cardiac Catheterisation Laboratory and has extensive experience in both routine and complex coronary intervention.

His interventional expertise includes complex coronary angioplasty and stenting, rotational atherectomy (rotablation), intravascular lithotripsy (shockwave therapy), drug-coated balloon treatment, pressure-wire assessment and intravascular imaging. He also holds Level 2 accreditation in Cardiac CT, enabling him to provide expertise in non-invasive assessment of coronary artery disease.

Alongside his clinical responsibilities, Dr Bhatia served as Interventional Governance Lead and was an accredited Educational Supervisor for trainee doctors with the UK General Medical Council. These roles reflect his commitment to clinical standards, patient safety and medical education.

Dr Bhatia relocated to Australia with his family in January 2026 and is now practising with Advara. He believes in providing patients with clear, evidence-based information and taking the time to understand their concerns, so that investigations and treatment decisions can be made collaboratively and with confidence.

Outside of work, Dr Bhatia enjoys competition-level tennis, reading, politics, football and music. His wife works as a local GP and they have 4 children.


Professional memberships

  • Member of the Royal College of Physicians UK
  • Fellow of the Royal Australasian College of Physicians
  • Doctor of Philosophy (PhD)

Publications

  1. Bhatia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J. 2012; 33(10):1190-200.
  2. Bhatia LS, Curzen NP, Byrne CD. Nonalcoholic fatty liver disease and vascular risk. Curr Opin Cardiol. 2012; 27(4):420-8.
  3. Bhatia L, Scorletti E, Curzen NP, Clough GF, Calder PC, Byrne CD. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression. Atherosclerosis. 2016; 246: 13-20
  4. Ripley DP, Gosling OE, Bhatia L, Peebles CR, Shore AC, Curzen N, Bellenger NG. The relationship between the contralateral collateral supply and myocardial viability on cardiovascular magnetic resonance: Can the angiogram predict functional recovery? Int J Cardiol. 2014; 177(2):362-7.
  5. Scorletti E, Bhatia L, McCormick K, Clough GF, Nash K, Hodson L, Moyses HE, Calder PC, Byrne CD. Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME study. 2014; 60(4): 1211-1221.
  6. Bhatia L, Byrne CD. There is a slight increase in incident diabetes risk with the use of statins, but benefits likely outweigh any adverse effects in those with moderate-to-high cardiovascular risk. Evid Based Med 2010; 15(3): 84-5
  7. Hodson L, Bhatia L (joint 1st author), Scorletti E, Smith DE, Jackson NC, Shojaee-Moradie F, Umpleby M, Calder PC, Byrne CD. Docosahexanoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study. Eur J Clin Nutr. 2017; 71(8): 973-979
  8. Scorletti E, West AL, Bhatia L, Hoile SP, McCormick KG, Burdge GC, Lillycrop KA, Clough GF, Calder PC, Byrne CD. Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: results from the WELCOME trial. J Hepatology. 2015; 63(6): 1476-83

Doctor locations

Friendly Society Private Hospital Bundaberg
Floor 1, 19-23 Bingera Street, Bundaberg QLD 4670

Specialties

Cardiology
Coronary Intervention